DJIA 16,960.57 -123.23 -0.72%
NASDAQ 4,449.56 -22.54 -0.50%
S&P 500 1,978.34 -9.64 -0.48%
market minute promo

Dendreon Corp (NASDAQ: DNDN)

2.14 -0.05 (-2.28%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

DNDN $2.14 -2.28%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.17
Previous Close $2.19
Daily Range $2.13 - $2.20
52-Week Range $1.81 - $5.38
Market Cap $342.3M
P/E Ratio -1.28
Dividend (Yield) $0.00 (0.0%)
Volume 956,526
Average Daily Volume 2,009,790
Current FY EPS -$0.77

Sector

Healthcare

Industry

Drugs

Dendreon Corp (DNDN) Description

A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer. Website: http://www.dendreon.com/

News & Commentary

These 5 Cancer Immunotherapy Companies All Have 1 Thing in Common

Cancer immunotherapies are all the rage on Wall Street, but these five immunotherapy-focused companies all have one big thing in common.

3 Convincing Reasons To Buy Dendreon

Why You Should Buy Dendreon's Drop

August 29th Options Now Available For Dendreon

Stocks To Watch Today: NQ Mobile, CBS, Seadrill...

Morning Market Movers

Benzinga's Top #PreMarket Gainers

New Provenge Data: Why Deerfield Investments Acquired A More Than 5% Stake In May

What Does Dendreon Need To Succeed?

Dendreon (DNDN) Stock Has Huge Short Interest: Time to Cover? - Tale of the Tape

Long Or Short: Cancer Cures

See More DNDN News...

DNDN's Top Competitors

DNDN $2.14 (-2.28%)
Current stock: DNDN
AMGN $122.84 (0.47%)
Current stock: AMGN
GILD $89.84 (-0.77%)
Current stock: GILD
BIIB $335.45 (-0.40%)
Current stock: BIIB